Vedolizumab blood levels with or without immunomodulators in patients with ulcerative colitis
Phase 4
- Conditions
- ulcerative colitis
- Registration Number
- ACTRN12618000812291
- Lead Sponsor
- Concord Repatriation General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method